Arphra
live
S&P 5000.34
NASDAQ0.00
DOW50,872.11+2.56%
VIX20.95+16.00%
US10Y4.53+1.21%
EUR/USD1.1576+0.37%
GOLD4,242.2+4.38%
WTI85.83-7.70%
BTC63,338+3.09%
S&P 5000.34
NASDAQ0.00
DOW50,872.11+2.56%
VIX20.95+16.00%
US10Y4.53+1.21%
EUR/USD1.1576+0.37%
GOLD4,242.2+4.38%
WTI85.83-7.70%
BTC63,338+3.09%

BIO

Bio-Rad Laboratories, Inc.
HealthcareMedical - DevicesUSUSDPeers →
$292.44
LiveJun 11, 2026
AI Brief
Market cap
$7.91B
52w range
222.80 – 343.12
P / E
EPS · FY 2025
$27.87
Volume
329.86K
Revenue · FY 2025
$2.58B
+0.65% YoY

Explain this page

Arphra AI
Business description
· company · SEC profile

Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.

Founded
IPO
Feb 27, 1980
Employees
7,700
HQ
Hercules, CA
CEO
Norman D. Schwartz
CFO
Exchange
NYSE
Fiscal year
Identifiers
· company_identifiers
CIK0000012208
CUSIP090572207
ISINUS0905722072
FIGIBIO US
LEI
Cross-listings
· companies · ISIN
  • BIO-BPrimaryNew York Stock ExchangeusUSD$8.32B
  • BIONew York Stock ExchangeusUSD$7.87B
The global universe keeps only the primary listing; the other venues for this security are shown here.